22 terminated. 22 Phase 2, 5 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 22 | Terminated 22 |
| Phase 1 | 5 | Terminated 5 |
| Phase 3 | 1 | Terminated 1 |
Follow MRI: new trials by email Literature Review of MRI trials Research Report on MRI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - CIC-Rearranged Sarcoma, Metastatic Ewing Sarcoma | Phase 2 / Phase 3 | Terminated | Children's Oncology Group | 2 | 2025-11-10 | 2026-10-05 |
| Testing the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial) Binimetinib, Biopsy Procedure, Biospecimen Collection - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 1 | 2024-09-13 | 2026-03-03 |
| Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study Apalutamide, Biopsy, Biospecimen Collection - Metastatic Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma | Phase 2 | Terminated | University of Washington | 8 | 2024-05-23 | 2026-10-19 |
| CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations Abiraterone Acetate/Niraparib, Biospecimen Collection, Bone Scan - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 2 | Terminated | Mayo Clinic | 8 | 2024-03-05 | 2026-07-22 |
| Rintatolimod, Celecoxib and Interferon Alpha 2b With Pembrolizumab For the Treatment of Patients With Metastatic or Unresectable Triple Negative Breast Cancer Biopsy, Biospecimen Collection, Celecoxib - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma | Phase 1 / Phase 2 | Terminated | Roswell Park Cancer Institute | 5 | 2024-02-16 | 2026-08-31 |
| Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer Chemotherapy, Stereotactic Body Radiation Therapy, Computed Tomography - Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 2 | Terminated | Mayo Clinic | 2 | 2023-07-18 | 2026-06-18 |
| 18F-DCFPyL PET/CT in Hepatocellular Carcinoma F18-FDG, MRI, CT - Hepatocellular Carcinoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 8 | 2023-01-18 | 2025-08-28 |
| Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer Biospecimen Collection, Bone Scan, Computed Tomography - Metastatic Urothelial Carcinoma, Platinum-Resistant Urothelial Carcinoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 1 | 2022-11-22 | 2025-08-17 |
| MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer MRI-guided Intensity-Modulated Radiation Therapy, Antiandrogen Therapy, PSMA PET Scan - Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8 | Phase 2 | Terminated | Thomas Jefferson University | 6 | 2022-11-16 | 2026-03-03 |
| Hyperpolarized 13C Pyruvate MRI for Treatment Response Assessment in Pancreatic Ductal Adenocarcinoma Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance Imaging (MRI) - Pancreatic Ductal Adenocarcinoma | Phase 2 | Terminated | Zhen Wang, MD | 7 | 2020-08-14 | 2023-11-13 |
| Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients Cyclophosphamide, Fludarabine, Aldesleukin - Gastrointestinal Cancer, Pancreatic Cancer | Phase 1 / Phase 2 | Terminated | National Cancer Institute (NCI) | 5 | 2019-05-16 | 2026-05-19 |
| Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer Gallium Ga 68-labeled PSMA-11, Magnetic Resonance Imaging, Positron Emission Tomography (PET) - Thyroid Gland Carcinoma | Phase 2 | Terminated | University of California, San Francisco | 12 | 2018-03-19 | 2021-06-29 |
| Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment [18F]Flutemetamol, [18F]fluoro-2-deoxy-D-glucose (FDG), Functional Magnetic Resonance Imaging (fMRI) - Breast Cancer | Phase 2 | Terminated | University of Utah | 15 | 2018-01-31 | 2024-11-20 |
| Ferumoxytol MRI in Assessing Response to Pembrolizumab in Patients With Glioblastoma Ferumoxytol, Laboratory Biomarker Analysis, Magnetic Resonance Imaging - Glioblastoma | Phase 2 | Terminated | OHSU Knight Cancer Institute | 52 | 2017-12-20 | 2025-09-09 |
| Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases Ferumoxytol, Laboratory Biomarker Analysis, Magnetic Resonance Imaging - Lung Carcinoma Metastatic in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7 | Phase 2 | Terminated | OHSU Knight Cancer Institute | 2 | 2017-11-03 | 2022-08-10 |
| Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1 Fluorine F 18 Ara-G, Positron Emission Tomography, Magnetic Resonance Imaging - Bladder Cancer | Phase 2 | Terminated | Lawrence Fong | 4 | 2017-03-07 | 2020-01-21 |
| Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies Pyruvate (13C), MRI - Prostate Cancer | Phase 1 / Phase 2 | Terminated | Rahul Aggarwal | 23 | 2016-10-20 | 2022-04-22 |
| Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression Enzalutamide, Ribociclib, Laboratory Biomarker Analysis - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 1 / Phase 2 | Terminated | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 52 | 2015-12-01 | 2026-04-22 |
| GA-68 DOTA-TOC of Somatostatin Positive Malignancies Computed Tomography (CT), Gallium Ga 68-Edotreotide, Magnetic Resonance Imaging (MRI) - Neuroendocrine Tumor, Paraganglioma | Phase 1 / Phase 2 | Terminated | University of California, San Francisco | 300 | 2014-06-23 | 2019-11-12 |
| Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases MMSE, QOL via FACT-Br, MRI - Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Terminated | Duke University | 1 | 2008-08-01 | 2019-02-26 |
Showing 20 of 22. Sign in to see all of them.
Prostatic Neoplasms (5) · Pancreatic Neoplasms (3) · Breast Neoplasms (2) · Urinary Bladder Neoplasms (2) · Brain Neoplasms (1) · Carcinoid Tumor (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Transitional Cell (1) · Colonic Neoplasms (1) · Gastrointestinal Neoplasms (1) · Glioblastoma (1) · Liver Neoplasms (1) · Multiple Myeloma (1) · Neoplasm Metastasis (1) · Neuroblastoma (1)
National Cancer Institute (NCI) (4) · Mayo Clinic (2) · OHSU Knight Cancer Institute (2) · University of California, San Francisco (2) · AHS Cancer Control Alberta (1) · Children's Oncology Group (1) · Duke University (1) · Lawrence Fong (1) · Rahul Aggarwal (1) · Roswell Park Cancer Institute (1) · SWOG Cancer Research Network (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Thomas Jefferson University (1) · University of Utah (1) · University of Washington (1)
United States (21) · Canada (1) · Puerto Rico (1)
Andrzej J. Jakubowiak, MD, PhD (1) · Barbara Campbell, MD (1) · Bhuvana A Setty (1) · Bora Lim (1) · Daniel S. Childs, MD (1) · Edward Neuwelt, MD (1) · Ellis Levine, MD (1) · Esther Mena Gonzalez, M.D. (1) · Hamidreza Aliabadi, MD (1) · Himanshu Nagar (1) · James C Yang, M.D. (1) · James E. Herndon, PhD (1) · Janet S. Biermann, MD (1) · Jessie DiNome, MD (1) · John H. Sampson, MD, PhD (1)
PMID 36367894, PMID 38041836, PMID 40950337
K08CA237809 (1), P01CA234212 (1), R01CA183071 (1), U10CA032102 (1), U10CA180821 (1), U10CA180868 (1), U10CA180886 (1)